INTRODUCTION
Orbital inflammatory syndrome (OIS)-previously known as idiopathic orbital inflammation, inflammatory orbital pseudotumor, or non-specific orbital inflammationis the most frequent cause of painful orbital masses in adults. [1, 2] The OIS incidence is between 4.7% and 6.3%, [3, 4] and it constitutes about 10% of orbital mass lesions. [1, 2] The etiological factors include thyroid disorders, systemic lupus erythematous, rheumatoid arthritis, IgG4-related disorders, sarcoidosis, and granulomatosis with polyangiitis. [5] [6] [7] [8] Pseudotumors are rarely infiltrative. Radiological findings were summarized as infiltration of the retrobulbar fat, enlargement of the extraocular muscles, thickening of the optic nerve/sheath complex, contrast enhancement, and proptosis. [9] Intracranial extension is rare, but it has been documented in up to 8.8% of patients. [10] Soft-tissue edema, decreased ocular motility, proptosis, decreased visual acuity, or pain can be seen clinically.
The OIS treatment mainly consists of steroids, and about 80% of patients are steroid responsive. [11] Also, 33%-58% of patients may have recurrent OIS. [12, 13] Patients with refractory OIS can be effectively treated with radiation therapy. [14, 15] Here, we present three cases of patients with refractory OIS who were treated with hypofractionated stereotactic radiotherapy (HSRT) with CyberKnife (Accuray Inc., Sunnyvale, CA, USA). We also present a short review of literature.
CASE SERIES
Case 1-A 39-year-old female patient was admitted to a hospital with diplopia occurring by down gaze and swelling on left eyelid for three months. Her biochemical and serological tests were normal. She had no systemic or rheumatologic condition. Her magnetic resonance imaging (MRI) revealed mass lesion located in left superior rectus muscle in left orbital that was compatible with pseudotumor or inflammation. She was given a two-month steroid treatment course with adequate dosing. Despite the steroid regimen, she had partial response, and she was referred to our center for radiotherapy option. After 1500 cGy (three fractions) HSRT with CyberKnife, the patient had complete clinical recovery. However, after 12 months of follow-up, repeat MRI showed partial regression.
Case 2-A 17-year-old male patient complained of swelling of left eyelid, and MRI showed a mass that invades superior oblique and superior rectus muscles in the left orbit. Lesion has shown very dense enhancing that was compatible with orbital pseudotumor. There was no rheumatological or neoplastic finding in his diagnostic tests. He was also given the steroid treatment. After two months of steroid treatment, there was no evident regression of lesion. Therefore, he was evaluated for radiotherapy. 2000 cGy radiotherapy 10 fraction protocol was applied to left orbit. After three months of follow-up, left-sided mass lesion showed complete resolution. Four months from the last visit, onset of new symptom was observed in the right eye. MRI showed 45×29 mm sized lesion compatible with pseudotumor. After the complete failure of two-month steroid regimen, 800 cGy radiotherapy with CyberKnife was applied to the right orbit as a single fraction. Recurrence was obtained at the seven-month control visit. Reirradiation was given as 10 fraction with a total dose of 2000 cGy. Regression was achieved after second radiotherapeutic approach.
Case 3-A 62-year-old female patient was admitted with right orbital swelling. Her MRI showed mass lesion of pseudotumor (Fig. 1) . She had no past medical history. Oral steroid treatment was started, but due to treatment resistance, radiotherapy was planned. After 1500 cGy HSRT (three fractions) with CyberKnife ( Fig. 2) , lesion showed full recovery (Fig. 3 ). After about a 12 month of follow-up, no recurrence was obtained.
DISCUSSION
OIS or orbital pseudotumor represents the most frequent cause of orbital masses. [1, 2] Most of the patients have monophasic disease course, but some of the patients can show recurrence. [16] In a study performed in 153 non-specific orbital inflammation with a single or multiple recurrences showed that younger age, bilateral disease, partial initial steroid response increased risk of recurrence. [16] Additionally, there may be some risk factors precipitating the disease recurrence in the presence of infection [17, 18] and autoimmune disease. [19, 20] Also, obesity, pregnancy, and bisphosphonate use may also cause disease recurrence. [20] In our case series, a patient showed disease recurrence despite the lack of presented risk factors except onset of young age.
Corticosteroids are usually preferred as the first-line treatment option. Dose of 80 mg/day for 1 week followed by tapering oral dose of prednisone is generally considered as the first-line treatment. [21] Most of the lesions were resolved under steroid treatment. [11] In a small number of patient group, low dose of cyclosporine alone or with the combination of prednisone has achieved to stabilize disease course in 1 or 2 years of treatment. [22] Methotrexate was successfully used in a group of non-infectious orbital inflammatory disease as a long-term therapy. [23] Adalimumab as a TNF-α blocker was able to control disease activity in two steroid dependent and treatment refractory patients. [24] Local therapy at doses between 20Gy and 30Gy is generally reserved for patients who fail to respond to medical treatments. These consisted of radiation therapy at conventional fractionation. [25] In refractory course or in the situation of pharmacologic treatment side effects or contraindications, radiotherapy may be considered as a treatment option. In a study consisting of 16 patients, 15 started with corticosteroids. [15] Eight patients had disease recurrence, and one had progression. [15] External-beam radiotherapy was applied to 14 patients. [15] Thirteen patients showed prominent improvement, but the rest of three patients could not have long-term control. [15] Another study with 20 patients revealed that 17 of the treatment group responded to radiotherapy. [14] Among responders, seven cases had partial recovery without an increase of steroid dose, one had complete response with a steroid dose reduction, and nine had complete response without steroid use. [14] HSRT with frameless stereotactic radiosurgery system provides a better optic apparatus protection and a short treatment time (3-5 fractions). In our cases, HSRT was effective, and it was safely used for treatment of orbital pseudotumor.
CONCLUSION
As a result, besides the steroids, chemotherapeutic agents or monoclonal antibodies radiotherapy seems to be an efficient treatment option.
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